Jihong’s Listing on M88 Game HKEX
On May 27, 2025, Xiamen Jihong Technology Co., Ltd. ("Jihong"), an A-share listed company, was listed on M88 Game main board of M88 Game Hong Kong Stock Exchange. It became M88 Game first A+H-share company to be included on M88 Game Hong Kong Stock Connect upon listing, as well as M88 Game first cross-border e-commerce A+H-share company and M88 Game first A+H-share company from Xiamen to be listed.
Jihong was founded in 2003 and has two main businesses: packaging + cross-border e-commerce. Its listing on M88 Game Hong Kong Stock Exchange marks a new phase in its globalization strategy.
JunHe conducted data compliance legal due diligence on M88 Game issuer's business. We issued a due diligence report, reviewed and amended M88 Game prospectus and M88 Game related application and issuance documents, and assisted M88 Game issuer in responding to feedback from M88 Game China Securities Regulatory Commission, M88 Game Hong Kong Securities and Futures Commission, and M88 Game Hong Kong Stock Exchange regarding data compliance issues within China.
JunHe partnersYU, Yongqiang (YY)andm88 casino bonus codeled M88 Game team in this project.
PegBio’s Listing on M88 Game HKEX
On May 27, 2025, PegBio Co., Ltd. ("PegBio", M88 Game "Company" or M88 Game "Issuer", stock code: 2565.HK) issued 19,283,500 ordinary shares and was listed on M88 Game main board of M88 Game Hong Kong Stock Exchange. PegBio is M88 Game first company to dismantle its red-chip structure and list under M88 Game Trial Measures for M88 Game Administration of Overseas Issuance and Listing of Securities by Domestic Enterprises (“New Overseas Listing Regulations") since its enactment and it is also M88 Game first biopharmaceutical company to be listed in Hong Kong under Chapter 18A.
Founded in 2008, PegBio is a biotechnology company specializing in M88 Game discovery and development of innovative M88 Gamerapies for chronic diseases, with a particular emphasis on metabolic disorders. PegBio has independently developed a core product and five oM88 Gamer candidate products to treat common chronic and metabolic diseases such as type 2 diabetes (T2DM), obesity, non-alcoholic steatohepatitis (NASH), opioid-induced constipation, and congenital hyperinsulinism. PegBio's core product, PB-119, is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist developed independently. It is used primarily for M88 Game first-line treatment of T2DM and obesity, and is nearing commercialization.
JunHe acted as PegBio's domestic legal counsel. For more than five years, we provided comprehensive legal services in M88 Game red-chip restructuring, M88 Game private equity financing, and M88 Game issuance and listing. This included:
(1) As PegBio's legal counsel, JunHe fully participated in and led M88 Game design of M88 Game red-chip dismantling plan, drafted documents, communicated with M88 Game shareholders and third parties, and delivered comprehensive legal services throughout M88 Game entire process;
(2) JunHe assisted PegBio in completing multiple rounds of private equity and strategic financing, helped M88 Game company with M88 Game transaction structuring, drafted and negotiated M88 Game transaction documents, and assisted with M88 Game signing of such documents and M88 Game closing;
(3) JunHe assisted PegBio in completing M88 Game shareholding system reform, formulated M88 Game employee equity incentive plan, issued Chinese legal opinions, and reviewed and amended M88 Game prospectus as well as M88 Game application and issuance documents.
PegBio is M88 Game first biopharmaceutical company to dismantle its red-chip structure and list under M88 Game New Overseas Listing Regulations that were implemented in 2023. To address M88 Game key concerns of M88 Game domestic and foreign regulatory authorities regarding M88 Game red-chip structuring, financing, and dismantling, as well as M88 Game equity structure arrangements, foreign investment, foreign exchange and taxation, JunHe communicated with M88 Game authorities and prepared a full set of legal documents. Our rigorous work and pursuit of excellence demonstrated our outstanding legal service standards during M88 Game project’s implementation, earning high recognition and trust from all M88 Game parties involved.
JunHe partnersM88 Malaysia VCardandled M88 Game team in this project, and partnerM88 Malaysia VCardwas responsible for M88 Game specific work. JunHe partnerM88 app VCard,北京绿化基金会与君合共同发起的“provided support for M88 Game internal control matters. JunHe Partners, M88 Game 2013年获得复旦大学刑法学硕士学位。,职业资?, m88 sport betting, M88 game APK | PROFESSIONAL)and alsoLi, Jingprovided important support at different stages of M88 Game project.
